成都恒瑞制药

Chengdu Hengrui Pharmaceutical is a key subsidiary of Jiangsu Hengrui Pharmaceuticals, one of China's largest and most innovative pharmaceutical companies. Established in 2004 and located in the Chengdu High-tech Zone, the company serves as a major R&D and manufacturing hub for the group's diverse portfolio. It specializes in high-end formulations, with a particular emphasis on medical imaging contrast agents, cardiovascular medications, and oncology therapeutics. The company's manufacturing facilities are built to meet international standards, including US FDA and EU GMP certifications, supporting its role in the global pharmaceutical supply chain. Chengdu Hengrui plays a vital role in advancing the parent company's mission to provide innovative and affordable healthcare solutions worldwide.